Greetings. Welcome to the Advanced Energy Third Quarter 2022 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Edwin Mok, Vice President of Strategic Marketing and Investor Relations. You may begin.

Thank you, operator. Good afternoon, everyone. Welcome to Advanced Energy third quarter 2022 earnings conference call. With me today are Steve Kelley, our President and CEO; and Paul Oldham, our Executive Vice President and CFO. Before I begin, I’d like to mention that we will be participating at several investor conferences in the coming months. If you have not seen our earnings press release and presentation, you can find them on our website at ir.advancedenergy.com. Let me remind you that today’s call contains forward-looking statements that are subject to risks and uncertainties that are that could cause actual results to differ materially and are not guarantees of future performance. Information concerning these risks can be found in our SEC filings. All forward-looking statements are based on management’s estimates as of today, November 1, 2022, and the company assumes no obligation to update them. Medium-term targets and long-term aspirational goals presented today should not be interpreted as guidance. On today’s call, our financial results are presented on a non-GAAP financial basis unless otherwise specified. Excluded from our non-GAAP results are stock compensation, amortization, acquisition-related costs, restructuring expenses, unrealized foreign exchange gains and gains from a onetime sales of a nonstrategic technology. A detailed reconciliation between GAAP and non-GAAP measures can be found in today’s press release. With that, let me pass the call to our President and Chief Executive Officer, Steve Kelley.

Thanks, Edwin. Good afternoon, everyone, and thanks for joining the call. Our third quarter was one for the record books, with over $500 million of revenue and more than $2 of earnings per share. In addition, we delivered strong cash flow. This outperformance was largely a function of improved component supply, our part qualification and redesigned efforts and good manufacturing execution. Demand for our products remained strong. 2/3 of our nearly $1.1 billion backlog is shippable in the next 2 quarters. That gives us opportunity for upside, should our critical component suppliers improve upon their current delivery commitments. In the near term, our tactical focus will be on operational execution, particularly the sourcing of critical components and the quick conversion of those components into product revenue. Strategically, we are focused on accelerating new product and technology development with the ultimate goal of achieving undisputed technology leadership in each of our target markets. Now, I'll provide some further color on the current supply environment. While we have started to see some improvements, the environment remains dynamic. Deliveries of critical ICs, which are largely produced on older process nodes, are still the biggest source of uncertainty in our production planning process. We continue to pay significant premiums for critical ICs and appreciate the continued support of our customers in helping to absorb some of those incremental costs. Our strategic decisions to maintain surge capacity and to aggressively mitigate parts shortages have allowed us to quickly convert lumpy deliveries of scarce components into revenue. This, in turn, has enabled much improved financial performance in 2022. Now, I'd like to provide some additional color on market demand. Currently, demand exceeds supply in many areas of our business. Solid end market demand, coupled with the need to replenish channel inventories and safety stocks, are the…

Thank you, Steve, and good afternoon, everyone. In the third quarter, we delivered extraordinary results across a range of financial metrics, demonstrating some of the pent-up earnings potential in the company. Increased supply of critical components, combined with the ability of our operations team to respond quickly, enabled us to deliver revenue of $516 million and EPS of $2.12 per share, both well above our guidance ranges. Backlog declined slightly to approximately $1.1 billion on much higher revenue, reflecting continued solid demand for our products. We continue to believe our backlog position and multiple AE-specific drivers should enable Advanced Energy to relatively outperform as our markets evolve over the next several quarters. Now, let me go over our financial results. Third quarter revenue was a record $560 million, growing 49% year-over-year and 17% sequentially. Revenue in the semiconductor market grew 54% from last year and 17% sequentially to $267 million. Improved supply and great operational execution allowed us to deliver upside in the quarter and achieve record revenue levels. Revenue in the industrial and medical market also reached a record $120 million, growing 48% from last year and 14% from the second quarter. Excluding SL Power, organic growth was 29% year-over-year and 12% sequentially, driven by strong market demand and improved supply of critical ICs. Improved supply also allowed us to grow data center computing revenue 41% year-over-year and 27% sequentially to $88 million, on par with 2020's record levels. Telecom & Networking revenue was $43 million, up 40% from last year and 12% from the second quarter. Third quarter gross margin was 37.5%, up 40 basis points from last quarter, due primarily to higher factory output, largely offset by continued premiums paid for scarce parts and unfavorable mix. Higher material costs and partial recoveries from our customers continue to…

[Operator Instructions] Our first question comes from the line of Quinn Bolton with Needham & Company.

Congratulations on the nice results. I guess, a couple of questions looking into next year. Obviously, the WFE environment is changing, and I think some of the big OEMs in this sector have talked about WFE down 20%. So my first question is, given your backlog position, the need for restocking, do you think you guys would do better than down 20% WFE environment within the semiconductor business? And my second question is, how do you see demand in the industrial, medical, telecom and server? Are those businesses – are you seeing demand hold up better in those end markets? Or are you starting to see some signs that orders in those markets are also beginning to trend lower?

Okay, Quinn, I'll take those. This is Steve. I think looking at 2023, without providing guidance, we definitely see 2023 as being down over 2022 when it comes to the semiconductor equipment demand. That's clear with the new export control regulations and the memory market correction and the softening in the advanced logic market that there are some issues there. But as I look forward, I also see some factors that are probably working in our favor. First of all, we usually work with our largest customers with just-in-time inventory bins. And those bins largely need to be refilled. So that's somewhat of a cushion as we move into the next year. With our other customers in semiconductor are non-Jap customers, most of those customers have moved to a just-in-case approach. And so they want to put in safety stock. And again, that's going to help us. Another key factor for us is our service business. Service, as I mentioned in the script, it was a $45 million business for us last quarter. So that's grown quite a bit over the past few years, largely because our installed base has grown. And also, we offer a lot more value-added services. Maybe talking about the semiconductor market in general. I view it in 3 basic categories. There's memory market, there's the leading-edge logic market and then there's the trailing edge market. And the memory market obviously goes through cycles connected to supplier investment and then consumer demand. And I think we're going through the latest cycle essentially. I think the big factor that people may not fully appreciate is the size of the trailing edge market. That market continues to be oversold, is reflected in the fact that we're still chasing parts. And that's, I think, the -- one of the largest pieces of the pie when it comes to semiconductors. So I think that market is going to be strong throughout 2023. And the other 2 markets will come back probably in the second half of next year. So that's what I see as far as semiconductors. Now looking at the other markets, industrial, medical, telecom, networking and data center and so forth. Right now, we don't see signs of softening there. In fact, we are still tackling a number of parts shortages in those areas. So we think there's a lot of upside there as our suppliers are able to improve their commitments we have a lot of current backlog that gets shipped over the next 2 quarters. The other key point with the rest of our business is we play in a wide variety of markets, and they operate in different cycles. So where one market may be down, others up, and overall, I think it's a much more stable environment than semiconductor.

Got it. And then just a quick follow-up for Paul. If I think about 2023, you mentioned the 300 basis points impact on higher material cost, including components. And some of that goes away as you get into next year, but it looks like your product mix probably becomes a headwind as semiconductor revenue probably going to decline more than the other end markets. And so from the 37 sort of percent level, how should we think about margins as they trend through next year? Do you think the recovery of component costs more than offset product mix? Do you think they’re about offsetting factors? I mean, any thoughts as you think about gross margins next year would be helpful.

That's a good question, Quinn. First, as we talked about the scarce component environment continues, and this last quarter was actually our highest quarter ever for premiums that we paid as well as premiums were recovered. But the point is we kind of thought earlier that might be starting to subside, and we haven't seen it yet. What that means is this impact of premium costs is going to continue certainly through the fourth quarter and into probably the first half of next year. Because remember, it will take us about a quarter or so for the full cost to roll through the P&L, even after the input costs start to come down. So I think we’re going to probably stay in this range for at least another couple of quarters. And then as those material costs subside, we – there’s no reason we shouldn’t pick up the vast majority of that 300 basis point recover, I’ll say, over time. So I think it’s going to be a slower progression to see margins recover over the course of next year. And I do think the material recovery will outweigh any shift in the mix that we see.

Our next question comes from the line of Scott Graham with Loop Capital Markets.

Terrific quarter, congratulations. Can you hear me?

I hear you, yes. Loud and clear.

Okay. Great, great. So I'm wondering, as we head into next year, I think we all appreciate your views on WFE and thought your trailing edge logic market being oversold as very interesting observation. It seems, however, that the memory side is weakening by the moment. And with some of the big memory makers down 50, and some of them are actually saying that just that might move out later into the year as well and maybe sort of less in the first quarter, maybe more in the second and third, depending upon who you speak with. And I’m just wondering, could you give us an idea of how you guys are – your semiconductor business is exposed. I assume that your tilted towards memory versus foundry logic. Could you help us understand your business itself?

Yes. I could talk in general about that. I think our business is more tilted towards foundry logic because the intensity of conductor etch equipment is higher in the logic side than is in the memory side. So we will certainly feel the memory slowdown. But we have to remember, memory is about, I think, roughly 35% to 40% of the total market today from a WFE standpoint. And so we're less exposed there than we are to the other part of the market, which is the logic, both leading edge and trailing edge logic together. What we see in memory is continued investment because they still need to invest for the next generation, right? They need to drive higher yields, more complex structures, and we're participating with those customers today to move to the next generation. So even though they may be pausing some of the capacity expansion, they're moving full speed ahead, new product development and new process development. So it's a great opportunity for us to get some new technology into those customers.

Okay. And I guess my next question, sort of an extension of that one is, you have an extremely high backlog, and I’m just wondering what those shipment schedules look like? I assume that they are not firm delivery dates, and that customers could push them back. Could you give us a little bit of flavor for maybe what the backlog sort of shipment schedule looks like and then how firm are those dates?

Yes, it's a good question, Scott. Look, we've seen our backlog be pretty consistent that the demand is close in. In fact, we've said and continue to see that our backlog from a customer request date, it's either -- they either want it now or they would like it within the next 2 quarters, so approximately 5 months, 2/3 of it. So it's current backlog. It's not backlog that's scheduled out over a long period of time that could be subject to change. Now as a practical matter, our customers can certainly reschedule backlog. But to date, we've seen more expedites and people continuing to ask for backlog than reschedule. So we feel like it's still a very good quality backlog. And it's going to take us a few quarters to actually work that down to a more normalized level. As Steve said, in many of our markets, the demand continues to exceed the supply.

Our next question comes from the line of Krish Sankar with Cowen.

I actually had a few of them. First one, just out of curiosity on the $1.1 billion in backlog, how much of that is semis?

We've said that the combination of semi and industrial medical represents about 80% of the total. So we haven't broken it out specifically, but it's in the ballpark of 50-50.

Got it. Got it. Fair enough. And then the other question I wanted to ask is, in the past downturn, clearly, if you look at this year, that outgrowing WFE is an upcycle. And typically, in down cycles, you actually underperformed WFE. So I’m kind of curious why wouldn’t that be the case next year? If you just assume that it’s a normal cyclical downturn, your customers are going to end up using up your inventory versus purchasing from you. So why would the behavior be different this time around?

Yes. I think the biggest difference is just a lack of inventory out there, Krish. So as we look into our direct customers and into their customers, there's very little inventory of our critical subsystems out there. So first of all, they're still pulling for immediate needs, installation needs. And second of all, they're going to pull from us to refill some of those JIT bins that have been depleted over the past 1.5 years. So I think it's a different type of correction for us. And I think if you combine that with some transitions that are occurring as people move to new technologies. We have a very good position there, and that also serves to counteract some of the down part of the cycle.

Got it. Got it. All right. Fair enough. And then just a final question for Paul. Can you just help us quantify what is the impact from the pass-through cost and gross margin this year? And if that thing normalizes next year or into the next few quarters, but your revenue decels, is this fair to be the negative leverage because of revenue deceleration would overwhelm any kind of tailwind you get from some of these supply cost leasing?

Yes, it's a good question. I guess we had quantified the impact of both the premium recoveries, which is essentially revenue that we're getting that's at 0 margin. That's about 150 basis this quarter. And if you go back over our last 2 or 3 conference calls, it's kind of been in the 150 to 100 basis points, 80 basis point range. You can do the math on that, Krish, but that's essentially calorie-free revenue, which means that revenue, we would expect to go down, but gross margin wouldn't change. That's going to make our model look better. And that will be a headwind to revenue next year, but won't change gross margins. In addition to that, we have about an equal amount of premiums that we're paying that we're not getting any recovery for. Those should also go away. That's not normal pricing from the supplier. That's premiums we're paying to brokers or other third parties to get the parts wherever we can. That will be real improvement to gross margin that will not only improve our model but improve earnings. And so it's going to be some trade-off. Clearly, there's some there will be negative leverage from lower revenue, some of that comes for free and some of it will impact our margins. But I think the better way to think about it is we should get that entire effectively 300 basis points back at some point in time as the supply chain normalizes. But we've also said there's 50 to 100 basis points of factory inefficiencies in our model. I think it's fair to say with the higher volumes this quarter, we probably got an equal amount of leverage this quarter. So it's kind of offsetting the inefficiencies, the higher volumes. So I think what you'll see is maybe we don't get as much back on the efficiencies that we would expect, that 50 to 100 basis points because of the negative leverage. And that's maybe the way to think of it.

Got it. Super helpful, Paul. If I could just squeeze in one more thing. If I heard you right on I&M revenues ex SL Power, was SL Power about $7 million in the quarter?

No, it was much higher than that. I think the number is about $17 million.

Our next question comes from the line of Mehdi Hosseini with SIG.

Paul, you said OpEx should be up. Did you mean to imply like in a $1 million to $2 million range?

Yes. It's up nominally. Go ahead, Mehdi.

Okay. Should I assume that this kind of OpEx throughout 2023 especially you’re expecting a pickup in semi business in the latter part of the ‘23?

Yes. I think what you'll see is it will be flat, maybe even down a little bit at the beginning as we focus on some efficiencies and whatnot. But as we go across the year, we've continued to battle inflation, which we continue to see on the horizon. And we intend to continue to invest particularly in our critical engineering programs and in strategies that will drive growth. So next year, obviously, we'll be with the softer market, we'll be focusing on where we can improve productivity, ensure we're delivering synergies and improve efficiency. And so I would expect to see spending flat to up, but not up much.

Got you. And then one question for Steve. Given the current valuation in the public market, how are you thinking about potential acquisition targets. Is there any area in semis, data centers, telecom, industrial that you offer better value? Or are you just focused on a strategic fit? Or is that a combination of the 2? Any color will be great as we try to better understand how you’re thinking about M&A strategy.

Yes. I think, in general, I think 2023 is going to be a favorable environment for us in M&A with high interest rates and a calmer market, I think that favors strategic buyers like Advanced Energy and allows us to pay reasonable prices for quality assets. Our strategy is the same. We're still looking for power companies in the semiconductor, industrial and medical markets. We like companies with a high portion of sole-source products. We like companies that have operated in the market for a while and have a good base of customers and have a strong engineering mindset. So that dovetails nicely with Advanced Energy.

I guess I was looking for something more specific. Is there any end market that offers you a better value? Or are opportunities equally distributed for different markets?

I think that what we like about semiconductor, industrial and medical is the ability to create customized products for our customers. So a very, very high percentage of products we ship into those markets are sole-sourced, and they're long life cycle and they're sticky. And we think that is our primary business. We're kind of in a high-mix, low-volume business. But these design wins turn into 15-year annuities essentially.

Our next question comes from the line of Hans Chung with D.A. Davidson.

Congratulations on the strong results. So first question, I want to follow-up on the margin. So I remember you talked about redesigning effort, and that could help to mitigate the supply chain constraint, right, either for the availability of component or the cost that you pay. So I just wonder how does that playing out so far? I think that it’s not helping a lot just based on your commentary around the impact from the cost premium. I just want to know what’s the progress now? And then how should we think about that being a tailwind going into next year?

Yes. Let me just clarify what Paul mentioned earlier. And the bottom line is the effect of the park charge has continued to shave about 300 basis points of our gross margin percentage. So instead of 40%, we're operating at 37%, roughly. Now our redesigns and alternative part qualifications are a different matter. They've allowed us to actually drive much higher revenues this year than last year, but we're still incurring significant costs for these scarce parts. And the list of scarce product is shorter than it was a year ago. But all it takes is one missing part and we can't build the box. So as we move into 2023, there's 2 primary factors is going to drive higher gross margin. First is the dissipation of these extraordinary what we call piece part variance charges. The second is a continuing improvement in our product mix. So all of our efforts in the past 1.5 years have been focused on sole-sourced products in all of our markets. We think this will drive a better mix moving forward so that we can operate above 40% gross margin in good times and bad. That's our basic financial objective as a company.

Got it. Okay. And then – so what about the operating leverage on the OpEx side, let’s say, going into ‘23 as we see that decline semi business? And how should we think about the model, the OpEx model to during the downturn?

Yes. I think as I mentioned earlier, this is the first quarter we've had a full quarter of SL Power and we were right just under $100 million. And I think we'll be very modestly in the fourth quarter. We will do some things to help moderate those costs, but we're also fighting inflation, and we're going to continue to invest in our strategic markets. So generally, you should think about operating expense as you go into next quarter as flat to up from the current run rate.

Got it. Okay. And then on the industrial market, I think they are seeing some back pockets of softness, I mean, just overall in the industry. I’m just wondering if you see any signs of weakening trends or changes in customer behavior, maybe in different sectors, I mean, across the market.

Yes. We haven't seen that. In fact, we're seeing the backlog stay very strong. And even though we outshipped by a significant margin, our forecast in I&M last quarter in Q3, our backlog was roughly flat. So that means we have new orders coming in to replace all of the shipments we're making. So that's -- I think that's impressive. What we're seeing is that in the markets we operate in, like test and measurement, horticulture, in other specialized markets, the demand is strong, and much of it is pent-up demand. We have undershipped into those markets for the past year. So we're still playing catch up. And we're going to be playing catcher for the next couple of quarters in those markets. But I think in general, we see industrial medical as very strong areas for us moving into 2023. And we think we can grow faster than the market, not only just based on our shipment improvements, but also based on our design win pipeline, which is much stronger than it’s been in quite some time as we kind of – we refocus as a company about a year ago on the industrial medical markets, and the sales team has done a great job winning a lot of new designs.

Our next question comes from the line of Steve Barger with KeyBanc Capital Markets.

Going back to the backlog, you said you don’t have a lot of direct exposure to Chinese-owned companies. But do you have an estimate for what percentage of the backlog could be affected by restrictions on U.S. customers?

Yes. If you look at the backlog overall, it's probably in the mid- to high single digits that would be currently allocated to those direct customers. So we'll see how that works out as we get more clarity about what can and can't be shipped. But if -- but all things else equal, you could think about our backlog around $1 billion ex any Chinese exposure.

Got it. If I look at 3Q revenue and the midpoint of the 4Q guide, the average is almost $500 million per quarter. You have, as you noted, $700 million of shippable backlog, if you get the parts. Orders still seem good, especially on industrial, medical. Should we be thinking that the average 2 half run rate, that almost $500 million, could be more of a base case for the first part of next year?

We're not providing guidance at this point. But I just think if you look at the relative mix of our business with semi and WFE, our customers have said WP down 20%. We should be down, as Steve articulated, less than that, but it's still down. And in the general, I'll say, broader macroeconomic environment, I think that would probably be a little high for a base case. So obviously, there's a lot of moving parts in the economy right now. I think however our markets perform, and that's maybe the first thing for you to form a view on is we should do better than that. We're entering the softer point from a supply-constrained environment, and so we'll have an opportunity to fill in some inventory. We have new products and other things that should help us to relatively outperform the markets. But I think that's the tough thing right now is looking at how the markets will perform 2022. And I think there's still a lot of moving pieces there, Steve.

Got it. I’ll ask one more. I know that securing wins in Industrial & Medical has been a big focus. As you’ve increased your sales and marketing, are you getting more inbound inquiries from new customers? Or can you talk about the percentage of customers that are finding you through marketing programs versus your direct sales channel? .

Yes, Steve, I can make some general comments. But I mean the first thing we did was we looked at our sales force, and roughly 40% of the people in our sales force are now solely incentivized on industrial and medical design wins and revenue. So we didn't have that before. And that was a key change. The second thing we did as a company was we transferred a number of development engineers from our high-volume programs, which were focused primarily on hyperscalers and networking customers, and we put them into the industrial medical group. And so that’s really opened up the pipe for engineering bandwidth, and we’ve been applying that horsepower to new opportunities across the world really. And so I think the company kind of refocused starting about 12 months ago on these applications, and we’re able to engage with the customer with a pretty broad portfolio today and they basically customize the products to their needs. And so it’s a powerful playbook. It’s going to continue to play out in the coming years, but it’s a great business because most of these design wins last a very long time, and the customers keep buying the product for as long as we make it.

Our next question comes from the line of Mark Miller with Benchmark.

Let me add my congratulations on your record results. Just had a question about your large backlog. How would you look at the margin profile of that backlog in terms of your recent margins? Would it be higher or the same? .

Yes. If you look at the backlog being 80% industrial and medical and semi, it's a generally margin up the company from our current run rate. I think the wildcard in that is how quickly do the premiums for -- that we're paying to get for parts abate? But generally, it ought to be the same or better in the backlog.

You indicated that SL Power sales were slightly less than $100 million. What was the profit from SL Power contribution?

I think we said SL Power was $17 million in the quarter of revenue. And we haven't talked about the specific performance of SL Power, but it's a business that operates in the mid- to high teens of EBITDA, and it continues to operate in that or a little better.

And we have reached the end of our question-and-answer session. And also this concludes today's conference, and you may disconnect your phone line at this time. Thank you for your participation.